Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilhan Lim

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Skeletal Radiology|November 29, 2014
Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacementKyoung Jin Chang, Chang-Bae Kong, Wan Hyeong Cho, et al.
Annals of Nuclear Medicine|April 3, 2021
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of <sup>225</sup>Ac-DOTA-rituximab using <sup>64</sup>Cu-DOTA-rituximabChul-Hee Lee, Ilhan Lim, Sang-Keun Woo, et al.
Contrast Media & Molecular Imaging|August 21, 2019
Prediction of Chemotherapy Response of Osteosarcoma Using Baseline <sup>18</sup>F-FDG Textural Features Machine Learning Approaches with PCASu Young Jeong, Wook Kim, Byung Hyun Byun, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 12, 2021
The Feasibility of <sup>64</sup>Cu-PSMA I&T PET for Prostate CancerChul-Hee Lee, Ilhan Lim, Sang-Keun Woo, et al.
Nuclear Medicine and Molecular Imaging|July 21, 2025
Cutoff SUVR of [<sup>18</sup>F]Florapronol PET for Differentiating Alzheimer's Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume CorrectionSu Yeon Park, Inki Lee, Ilhan Lim, et al.
Biomedicines|January 23, 2024
PET/MRI and Novel Targets for Breast CancerHyun Woo Chung, Kyoung Sik Park, Ilhan Lim, et al.
Plos One|September 26, 2022
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapyJoon Ho Choi, Ilhan Lim, Byung Hyun Byun, et al.
Plos One|April 22, 2016
Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing SarcomaJae Pil Hwang, Ilhan Lim, Chang-Bae Kong, et al.
Nuclear Medicine and Molecular Imaging|April 18, 2018
The Predictive Values of Lesion Size, F-18 FDG Avidity and I-131 Avidity for the Clinical Outcome of I-131 Treatment in Patients with Metastatic Differentiated Thyroid Carcinoma Only in the LungJoon Ho Choi, Byung Hyun Byun, Ilhan Lim, et al.
Cancers|June 2, 2021
Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using <sup>18</sup>F-FDF PET/CT, <i>EZRIN</i> and <i>KI67</i>Byung-Chul Kim, Jingyu Kim, Kangsan Kim, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Skeletal Radiology|November 29, 2014
Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacementKyoung Jin Chang, Chang-Bae Kong, Wan Hyeong Cho, et al.
Annals of Nuclear Medicine|April 3, 2021
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of <sup>225</sup>Ac-DOTA-rituximab using <sup>64</sup>Cu-DOTA-rituximabChul-Hee Lee, Ilhan Lim, Sang-Keun Woo, et al.
Contrast Media & Molecular Imaging|August 21, 2019
Prediction of Chemotherapy Response of Osteosarcoma Using Baseline <sup>18</sup>F-FDG Textural Features Machine Learning Approaches with PCASu Young Jeong, Wook Kim, Byung Hyun Byun, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 12, 2021
The Feasibility of <sup>64</sup>Cu-PSMA I&T PET for Prostate CancerChul-Hee Lee, Ilhan Lim, Sang-Keun Woo, et al.
Nuclear Medicine and Molecular Imaging|July 21, 2025
Cutoff SUVR of [<sup>18</sup>F]Florapronol PET for Differentiating Alzheimer's Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume CorrectionSu Yeon Park, Inki Lee, Ilhan Lim, et al.
Biomedicines|January 23, 2024
PET/MRI and Novel Targets for Breast CancerHyun Woo Chung, Kyoung Sik Park, Ilhan Lim, et al.
Plos One|September 26, 2022
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapyJoon Ho Choi, Ilhan Lim, Byung Hyun Byun, et al.
Plos One|April 22, 2016
Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing SarcomaJae Pil Hwang, Ilhan Lim, Chang-Bae Kong, et al.
Nuclear Medicine and Molecular Imaging|April 18, 2018
The Predictive Values of Lesion Size, F-18 FDG Avidity and I-131 Avidity for the Clinical Outcome of I-131 Treatment in Patients with Metastatic Differentiated Thyroid Carcinoma Only in the LungJoon Ho Choi, Byung Hyun Byun, Ilhan Lim, et al.
Cancers|June 2, 2021
Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using <sup>18</sup>F-FDF PET/CT, <i>EZRIN</i> and <i>KI67</i>Byung-Chul Kim, Jingyu Kim, Kangsan Kim, et al.
Pageof 7